Skip to main content
. 2021 Dec;25(Suppl 3):S230–S240. doi: 10.5005/jp-journals-10071-24068

Table 9.

Clinical classification of pulmonary hypertension (World Symposium of Pulmonary Hypertension)

SI. No. Entity of pulmonary hypertension (PHT) Management
1.1 Idiopathic/Primary
  • Symptomatic treatment to prevent right ventricular failure and hypoxemia

  • Avoid conception if possible

  • Hospital admission in second trimester

  • ICU care for decompensation and in third trimester.

  • Early cardiologist care during antenatal visits, labor, delivery, and postpartum period

1.2 Heritable
  • Includes familial and simplex PAH

  • Autosomal dominant inheritance

  • Mean survival is 2.8 years after diagnosis

  • Significant stress of pregnancy in HPAH with high maternal mortality rates

  • Early cardiologist intervention, monitoring of right ventricular function, genetic studies

  • Use of suitable contraceptive measures

1.3 Drugs and Toxin induced
  • Exposure to appetite suppressants like aminorex, fenfluramine derivatives, benfluorex (withdrawn from the market)

  • Amphetamines, phentermine, mazindol, Dasatinib, and interferons associated with PAH

  • Identifying and stopping the implicating agent are vital for survival and reversibility

  • Counseling regarding contraception and psychological support

1.4 Associated with • Treatment of connective tissue disease with disease-modifying agents and antiretroviral therapy will need modification in pregnancy to prevent fetotoxicity
1.4.1 Connective tissue diseases • Concurrent pulmonary hypertension in these patients heralds a poor feto-maternal prognosis during pregnancy and labor.
1.4.2 HIV infection • A multidisciplinary team approach with early involvement of cardiologist, rheumatologist, physician, and obstetrician
2 PAH associated with heart disease (left ventricular dysfunction, congenital heart disease, valvular heart disease, cardiomyopathy)
  • Optimization of the primary cardiac disease

  • ICU admission for cardiac failure, arrhythmias, hypoxia, Eisenmenger syndrome

  • Infective endocarditis prophylaxis

  • Pulmonary vasodilators under the direct supervision of a cardiologist

3 PAH associated with lung disease or hypoxia
  • Detected on chest examination, pulmonary function testing, and high-resolution computed tomographic lung imaging

  • The unfavorable feto-maternal outcome in these cases with pregnancy due to poor cardiorespiratory reserve and pregnancy-induced stress

  • Patients to continue home oxygen therapy along with medications for their lung disease

  • Early involvement of cardiologist, pulmonologist, and intensivist (especially if ventilatory support is required)

4 PAH due to pulmonary embolism or diseases of large pulmonary vessels
  • Screening is done by lung perfusion scanning

  • Minimize radiation exposure for investigations during pregnancy

  • In chronic thromboembolic pulmonary hypertension (CTEPH), surgical thrombo-endarterectomy may be considered before conception

  • Early involvement of cardiologist and cardiothoracic vascular surgeon in care

  • Consider DVT prophylaxis as per institutional protocol.